XML 21 R12.htm IDEA: XBRL DOCUMENT
v3.23.2

Equity Incentive Plans | 6 Months Ended
--- | ---
Jun. 30, 2023
Equity Incentive Plans [Abstract] |
Equity Incentive Plans | Note 4 – Equity Incentive Plans Equity Incentive Plans Under the 2018 Equity Incentive Plan, on January 12, 2022, awards of 33,000 shares of restricted stock, in aggregate, were declared for members of the Board of Directors of the Bank and the Company, which vest over a 4-year period, commencing on the anniversary of the award date. On September 30, 2022, awards of 36,000 shares of restricted stock, in aggregate, were declared for certain executive officers of the Bank and the Company, which fully vested on November 30, 2022. On January 31, 2023, awards of 27,000 shares of restricted stock, in aggregate were declared for members of the Board of Directors of the Bank and the company, which vest over a 4-year period, commencing on the anniversary of the award date. The Company, under the plan approved by its shareholders on April 27, 2023 (“2023 Equity Incentive Plan”), authorized the issuance of up to 1,000,000 shares of common stock of the Company pursuant to grants of stock options, restricted stock awards, restricted stock units, and performance awards. Employees and directors of the Company and the Bank are eligible to participate in the 2023 Equity Incentive Plan. All stock options will be granted in the form of either "incentive" stock options or "non-qualified" stock options. Incentive stock options have certain tax advantages that must comply with the requirements of Section 422 of the Internal Revenue Code. Only employees are permitted to receive incentive stock options. On June 30, 2023, an award of 25,252 shares of restricted stock was declared for a director and executive officer of the Bank and the Company, which fully vests on the anniversary of the award date. ‎ Note 4 – Equity Incentive Plans (Continued) The following table presents a summary of the status of the Company’s restricted shares as of June 30, 2023 and 2022.
| Number of Shares Awarded |  |  | Weighted Average Grant Date Fair Value
Non-vested at January 1, 2023 | 48,150 |  | $ | 14.83
Granted | 27,000 |  |  | 17.99
Vested | (13,650) |  |  | 14.60
Forfeited | - |  |  | -
Non-vested at June 30, 2023 | 61,500 |  | $ | 16.27
| Number of Shares Awarded |  |  | Weighted Average Grant Date Fair Value
Non-vested at January 1, 2022 | 26,700 |  | $ | 12.89
Granted | 33,000 |  |  | 16.00
Vested | (6,750) |  |  | 12.89
Forfeited | - |  |  | -
Non-vested at June 30, 2022 | 52,950 |  | $ | 14.83
Restricted stock expense for the six months ended June 30, 2023 and June 30, 2022 was $151,000 and $54,000, respectively. Expected future expenses relating to the non-vested restricted shares outstanding as of June 30, 2023 was approximately $813,000 over a weighted average period of 2.93 years. The following table presents a summary of the status of the Company’s outstanding stock option awards as of June 30, 2023.
|  | Number of Option Shares |  |  | Range of Exercise Prices |  |  | Weighted Average Exercise Price
Outstanding at January 1, 2023 |  | 1,036,975 |  | $ | 9.03-13.68 |  | $ | 11.72
Options granted |  | - |  |  | - |  |  | -
Options exercised |  | (61,000) |  |  | 9.03 |  |  | 9.03
Options forfeited |  | - |  |  | - |  |  | -
Options expired |  | - |  |  | - |  |  | -
Outstanding at June 30, 2023 |  | 975,975 |  | $ | 10.55-13.68 |  | $ | 11.89
As of June 30, 2023, stock options which were granted and were exercisable totaled 772,895. It is Company policy to issue new shares upon share option exercise. Compensation expense for the six months ended June 30, 2023 and June 30, 2022 was $65,000 and $88,000, respectively. Expected future compensation expense relating to the 203,080 shares of unvested options outstanding as of June 30, 2023 was $331,000 over a weighted average period of 3.32 years. ‎

X
- Definition The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 710 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//710/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 712 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//712/tableOfContent Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 715 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//715/tableOfContent Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent + Details
Name: | us-gaap_CompensationAndEmployeeBenefitPlansTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CompensationAndRetirementDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration